Sterile Tubing Welder Market Size, Share & Trends Analysis Report By Mode (Automatic, Manual), By Application (Biopharmaceutical, Blood Processing), By End Use (Hospitals, Research Clinics), And Segment Forecasts, 2022 - 2030

Report Overview

The global sterile tubing welder market size was valued at over USD 2.2 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.8% over the forecast period. Increasing demand from end-use industries and a rise in investments in R&D projects are anticipated to drive market growth. Furthermore, a rise in the usage of single-use technologies and increasing demand for blood & blood products are anticipated to further boost the market growth. In the U.S., nearly 20 million units of platelets, plasma, and red blood cells are transfused for the treatment of hematologic conditions, such as sickle cell disease, severe anemia, and leukemia, annually.

Such high demand for blood products is anticipated to fuel the demand for blood processing, sterile processing, and related infrastructure. The extensive ongoing biopharmaceutical research for the development of innovative and therapeutically advanced medicines is anticipated to drive the market. For instance, according to the report published by the Pharmaceutical Research and Manufacturers of America, nearly 8,000 medicines are in the development phase across the globe and around 74% of these pipeline drugs are anticipated to be first-in-class medicines. Some of the key therapeutic categories covered by these development medicines are genetic disorders, Amyotrophic lateral sclerosis, cancer, and hemophilia, thus facilitating market growth. During the pandemic in 2020, there was a halt in the manufacturing of various products; however, the pharmaceutical industry was at the forefront of expanding its capabilities.

In line with the same, numerous technological advances and the purchase of equipment to promote faster turnaround times were witnessed. The automated sterile tubing welders too contributed to the same and have emerged to regain their y-o-y growth rate of 4.6%. In fact, post-pandemic, we have identified that a number of new biopharmaceutical research facilities are expected to be set up across countries, such as Sweden, the Netherlands, Ireland, Scotland, etc. According to the “National Plan for Industrial Biotechnology” published by IBioIC, which is a networking organization set up to boost the biotech industry in Scotland, the region is expected to establish facilities for 220 companies by 2025 with an overall employee strength of 4,000 people.

These facilities are expected to be installed with state-of-the-art equipment. This, in turn, is expected to promote the necessity of sterile tubing welders, hence supporting market growth over the forecast period. The revised cumulative CAGR over the forecast period is now 5.8%. Furthermore, the hematology community has witnessed several advancements in the field of bio-engineering and high-tech cell therapies in the past decade. The development of techniques to isolate specialized cells from the blood, such as Hematopoietic Progenitor Cells (HPC), has improved the extraction process and donor safety, thereby increasing the demand for HPC transplantation and indirectly facilitating the demand for blood processing and sterile processing systems.

Mode Insights

On the basis of modes, the global market has been further categorized into manual and automatic. In 2021, the automatic welder segment dominated the global market and accounted for more than 83.0% of the overall revenue share. The segment is anticipated to retain its leading position throughout the forecast period owing to the improved weld quality and user-friendliness of these welding machines. Automatic welding machines enable the setting up of weld speed and time without requiring a highly trained professional and the relatively higher weld speed of the device outpaces a skilled welder, thereby reducing the dependency on human labor. Thus, increased output and reduced labor costs are anticipated to increase the demand for these devices.

Manual sterile tubing welders typically require skilled professionals who are aware of safety protocols and current good manufacturing practices. These jobs require knowledge-specific skills and lack of knowledge on how to operate the devices could result in risk of contamination. Thus, a lack of skilled professionals can limit market growth. Comparatively, automated devices reduce weld & operator time, lower scrap & labor costs, offer good weld quality, and are easy to use. The automatic machines also have temperature monitoring sensors and blade controllers that help yield better results. These benefits of automatic devices are anticipated to fuel their demand.

Application Insights

On the basis of applications, the global market has been segmented into biopharmaceutical, blood processing, diagnostic laboratories, and others. The blood processing segment dominated the global market in 2021 and accounted for the largest revenue share of more than 61.00%. The segment is anticipated to witness lucrative growth over the forecast period. Increasing demand for blood & blood products is anticipated to be the key driver for the segment. This can be attributed to the high demand for personalized medicine, cell & gene therapies, and the high prevalence of blood disorders, such as hemophilia. For instance, hemophilia is estimated to affect nearly 1,125,000 men across the globe.

Hospitals are adopting sophisticated devices to reduce patient turnaround time and meet the increasing demand. The use of complex sophisticated devices has, in turn, led hospitals to reevaluate sterile processing departments and equipment to meet the infection control standard. Furthermore, the presence of transfusion committees in hospitals is anticipated to ensure the use of sterile equipment for quality transfusions and patient safety. According to the WHO, transfusion committees are present in nearly 68% of European, 40% of South Pacific, 57% of Eastern Mediterranean, 17% of the Americas, 79% of Southeast Asian, and 12 % of African hospitals. Based on these statistics, it is estimated that the needs will increase over the forecast period, hence hospitals are also expected to witness lucrative growth rates from 2022 to 2030.

End-use Insights

On the basis of end-uses, the global market is further categorized into hospitals, research clinics, blood centers, and others. The hospitals segment dominated the global market in 2021 and accounted for the maximum share of more than 41.00% of the overall revenue. The segment is anticipated to grow lucratively over the forecast period on account of the presence of various advanced hematology-related equipment in hospital settings. In addition, the availability of a range of wide treatment options in hospital facilities has also increased the number of visits for diagnosis and treatment of blood disorders in these facilities.

Blood centers are also anticipated to witness a substantial growth rate during the forecast period. This can be attributed to an increase in the demand for blood & blood products for the treatment of various blood disorders, such as leukemia, thalassemia, severe anemia, and others. In addition, an increase in the cases of road accidents across the globe is anticipated to augment the demand for blood & blood products. Thich, in turn, is also estimated to facilitate the growth of the global market during the forecast period.

Regional Insights

North America dominated the global market in 2021 and accounted for more than 38.5% of the global revenue share in the same year. An increase in the prevalence of chronic diseases, recent technological advancements, and high demand for hygienic & sterile environments to avoid contamination are some of the major factors contributing to the growth of the market in this region. The growing burden of chronic diseases in the U.S. is one of the key factors boosting the market growth. According to the National Health Council 2020 report, about 157 million individuals are estimated to have at least one chronic condition.

It is also estimated that 7 out of 10 deaths occur due to a chronic illness with kidney failure as one of the major conditions in the U.S. The Asia Pacific region is expected to grow at a rapid pace over the forecast period. An increase in the number of major multinational companies investing in research & development in this region has proved to be a major factor driving the growth of the pharmaceutical & biopharmaceutical industries. In addition, a rise in the geriatric population and presence of a large fraction of the population belonging to middle-income group significantly increases the demand for innovative & cost-effective sterile tubing welder devices to attract key medical device companies within the region.

Key Companies & Market Share Insights

This industry is highly fragmented with the presence of numerous mid-sized players; however, owing to continuous efforts toward mergers & acquisitions as a key strategic decision by top market players, the market has witnessed numerous such deals. For instance, in 2017, Terumo acquired a vascular closure business and certain assets of Abbott and St. Jude. Similarly, Sartorius acquired the selected life sciences business of Danaher for nearly USD 750 million in cash in 2019. This transaction was completed in 2020 and is expected to strengthen the company’s bioanalytical & bioprocessing segments. Key companies operating in the global sterile tubing welder market include:

• Sartorius Stedim Biotech S.A.

• Terumo BCT Inc

• GE Healthcare

• MGA technologies

• VANTE Biopharm

• Genesis BPS

• Biomen Biosystems Company Ltd.

• Flex Concepts Inc.

• Shanghai Le Pure Biological Technology Co., Ltd.

Sterile Tubing Welder Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global sterile tubing welder market report on the basis of mode, application, end-use, and region:

• Mode Outlook (Revenue, USD Million, 2018 - 2030)

  • Manual

  • Automatic

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Biopharmaceutical

  • Blood Processing

  • Diagnostic Laboratories

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Research Clinics

  • Blood Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE